Vaccination of follicular lymphoma

2006/01/01 Elhuyar Zientzia Iturria: Elhuyar aldizkaria

• Medikuntza

A team of researchers from the University Clinic of Navarra and the Center for Applied Medical Research has proven the efficacy and clinical usefulness of a vaccine against follicular lymphoma.

Follicular lymphoma is a type of blood cancer, a tumor of the lymphatic system. The cells contain a superficial protein, immunoglobulin, and the vaccine comes from this protein, which aims to affect the patient's immune system.

The vaccine is given subcutaneously and in particular is complementary to chemotherapy. The vaccine has also been used as a first treatment, but the results have not been good.